A Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Administered With and Without an Adjuvant Patch in Healthy Adults

Trial Profile

A Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Administered With and Without an Adjuvant Patch in Healthy Adults

Completed
Phase of Trial: Phase I/II

Latest Information Update: 13 Mar 2012

At a glance

  • Drugs KD 295 (Primary) ; Heat-labile enterotoxin E coli
  • Indications Influenza A virus H5N1 subtype; Influenza A virus infections
  • Focus Adverse reactions
  • Sponsors Intercell USA
  • Most Recent Events

    • 09 Sep 2008 Planned end date changed from 1 Apr 2008 to 1 Jun 2008, according to ClinicalTrials.gov.
    • 07 Sep 2008 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
    • 20 Mar 2008 Key endpoint met, according to an Ioma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top